Zheng B - Search Results

1

ERBB2 S310F mutation independently activates PI3K/AKT and MAPK pathways through homodimers to contribute gallbladder carcinoma growth.

Fan K, Wang J, Shen S, Ni X, Gong Z, Zheng B, Sun W, Suo T, Liu H, Ni X, Liu H. Fan K, et al. Among authors: zheng b. Med Oncol. 2022 Apr 28;39(5):64. doi: 10.1007/s12032-021-01568-w. Med Oncol. 2022. PMID: 35477796

2

LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma.

Shen S, Wang J, Zheng B, Tao Y, Li M, Wang Y, Ni X, Suo T, Liu H, Liu H, Zhang J. Shen S, et al. Among authors: zheng b. Mol Ther Nucleic Acids. 2020 Mar 6;19:446-457. doi: 10.1016/j.omtn.2019.11.028. Epub 2019 Nov 30. Mol Ther Nucleic Acids. 2020. PMID: 31902744 Free PMC article.

3

MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth.

Fan K, Wang J, Sun W, Shen S, Ni X, Gong Z, Zheng B, Gao Z, Ni X, Suo T, Liu H, Liu H. Fan K, et al. Among authors: zheng b. Exp Cell Res. 2020 Sep 1;394(1):112118. doi: 10.1016/j.yexcr.2020.112118. Epub 2020 Jun 2. Exp Cell Res. 2020. PMID: 32502493 Free article.

4

The lnc-CITED2-2:1 inhibits metastasis via inhibiting CITED2 and epithelial-mesenchymal transition in gallbladder cancer.

Shen S, Wang JW, Zheng BH, Ni XJ, Gao ZH, Zhang DX, Lu PX, Ni XL, Suo T, Liu HB, Liu H. Shen S, et al. Clin Transl Med. 2020 Jun;10(2):e116. doi: 10.1002/ctm2.116. Epub 2020 Jun 24. Clin Transl Med. 2020. PMID: 32578934 Free PMC article. No abstract available.

5

Carboxyl-terminal polypeptide fragment of MUC16 combing stathmin1 promotes gallbladder cancer cell migration and invasion.

Fan K, Zhang D, Li M, Shen S, Wang J, Ni X, Gong Z, Zheng B, Gao Z, Ni X, Suo T, Liu H, Liu H. Fan K, et al. Among authors: zheng b. Med Oncol. 2020 Nov 16;37(12):114. doi: 10.1007/s12032-020-01438-x. Med Oncol. 2020. PMID: 33196934

6

Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.

Zheng BH, Shen S, Wong KF, Gong ZJ, Sun WT, Ni XJ, Wang JW, Hu MY, Liu H, Ni XL, Liu HB, Luk JM, Suo T. Zheng BH, et al. J Surg Oncol. 2021 Apr;123(5):1253-1262. doi: 10.1002/jso.26399. Epub 2021 Feb 1. J Surg Oncol. 2021. PMID: 33524213

7

Knockdown of SLC39A4 Expression Inhibits the Proliferation and Motility of Gallbladder Cancer Cells and Tumor Formation in Nude Mice.

Li M, Fan K, Zheng B, Zekria D, Suo T, Liu H, Shen S, Liu H, Ni X. Li M, et al. Among authors: zheng b. Cancer Manag Res. 2021 Mar 8;13:2235-2246. doi: 10.2147/CMAR.S282269. eCollection 2021. Cancer Manag Res. 2021. PMID: 33727860 Free PMC article.

8

Adjuvant Therapy in Resected Nonmetastatic Stage II-IV Gallbladder Cancer: A Generalized Propensity Score Analysis.

Wan W, Zheng B, Sun W, Wang J, Shen S, Huang L, Liu H, Ni X, Liu H. Wan W, et al. Among authors: zheng b. Oncol Res Treat. 2021;44(7-8):390-399. doi: 10.1159/000517113. Epub 2021 Jul 2. Oncol Res Treat. 2021. PMID: 34218220

9

A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor Survival.

Ni X, Wan W, Ma J, Liu X, Zheng B, He Z, Yang W, Huang L. Ni X, et al. Among authors: zheng b. Front Genet. 2021 Jun 18;12:682503. doi: 10.3389/fgene.2021.682503. eCollection 2021. Front Genet. 2021. PMID: 34220957 Free PMC article.

10

The Biological Function of TUSC7/miR-1224-3p Axis in Triple-Negative Breast Cancer.

Zheng BH, He ZX, Zhang J, Ma JJ, Zhang HW, Zhu W, Shao ZM, Ni XJ. Zheng BH, et al. Cancer Manag Res. 2021 Jul 17;13:5763-5774. doi: 10.2147/CMAR.S305865. eCollection 2021. Cancer Manag Res. 2021. PMID: 34305410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,666 results

Search Page

Filters